Search results
Results from the WOW.Com Content Network
Lineage B.1.617 is a lineage of SARS-CoV-2, the virus that causes COVID-19. [1] It first came to international attention in late March 2021 after the newly established INSACOG performed genome sequencing on positive samples throughout various Indian states.
The SARS-CoV-2 Kappa variant is also known as lineage B.1.617.1 and was first detected in India in December 2020. [2] By the end of March 2021, the Kappa sub-variant accounted for more than half of the sequences being submitted from India. [3] On 1 April 2021, it was designated a Variant Under Investigation (VUI-21APR-01) by Public Health ...
The quickly changing coronavirus has spawned yet another super contagious omicron mutant that’s worrying scientists as it gains ground in India and pops up in numerous other countries, including ...
With 234,000 new cases, in addition to 1,341 new deaths, India recorded more than 1.6 million cases in the span of a week. As hospitals reached capacity, numerous reports indicated that many people died whilst awaiting treatment at and outside of hospitals or after being turned away. [34]
The first cases of COVID-19 in India were reported on 30 January 2020 in three towns of Kerala, among three Indian medical students who had returned from Wuhan, the epicenter of the pandemic. [ 10 ] [ 11 ] [ 12 ] Lockdowns were announced in Kerala on 23 March, and in the rest of the country on 25 March.
The first case of the COVID-19 pandemic in the Indian state of Haryana was reported on 4 March 2020. [1] The Ministry of Health and Family Welfare has confirmed a total of 2,64,955 positive cases as of 10 January 2021 out of which 2,510 are still active and 2,950 deaths so far.
The Beta variant, [1] [2] (B.1.351), [a] was [5] [6] a variant of SARS-CoV-2, the virus that causes COVID-19. One of several SARS-CoV-2 variants initially believed to be of particular importance , it was first detected in the Nelson Mandela Bay [ 7 ] metropolitan area of the Eastern Cape province of South Africa in October 2020, [ 8 ] which was ...
In week 8, the variant was found to have a dominant share of 56.4% (758/1345) according to the interpretable results of a weekly genome sequencing survey comprising 0.9% of all COVID-19 positive tests, or 59.5% according to a variant-specific RT-PCR survey testing 54% of all the COVID-19 positive tests. [124]